JaniceKirschMD

Physician

Dr. Kirsch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of California (San Francisco)Residency, Occupational Medicine, 1997 - 2000
University of California, BerkeleyM.P.H., 1997 - 1998
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1984 - 1987
University of California (San Francisco)Residency, Internal Medicine, 1981 - 1983
New York Presbyterian Hospital (Cornell Campus)Internship, Internal Medicine, 1980 - 1981
University of California San Francisco School of MedicineClass of 1980
University of California Division of Agriculture and Natural ResourcesA.B., Zoology, with Highest Distinction, 1974 - 1976
California State UniversityNo Degree, 1972 - 1974

Awarded American Cancer Society Preventitive Medicine Training Grant 1997
Visiting Research Scientist University of California, Berkeley, CA, 1996
Awarded Clinical Scholars' Research Grant at Memorial Sloan-Kettering Cancer Center 1987
Elected to Alpha Omega Alpha U.C.S.F., 1980
member Alpha Omega Alpha, 1979
Recipient of Dean's Prize for Medical Student Research 1978
Elected to Phi Beta Kappa U.C. Berkeley, 1977
member Phi Beta Kappa, 1976
Join now to see all

PubMed

Journal Articles

Development and evaluation of parental occupational exposure questionnaires for a childhood leukemia study
Reinier K, Hammond SK, Buffler PA, Gunier RB, Lea CS, Quinlan P, Kirsch J., Scand J Work Environ Health, 1/1/2004
The effect of 5-fluorouracil on cells in culture; Reversal of cytotoxicity by exogenous purines
Ullman, B. and Kirsch, J, Molecular Pharmacology, 1/1/1978

Books/Book Chapters

Gulf War and Health. Volume 2. Insecticides and Solvents.
Colwill, J.M., et alNational Academies Press, Washington, DC2003
Dead Reckoning: The Department of Energy and Workers' Health
Geiger, J. H., et alWilliam and Wilkens, New York, NY1990

Abstracts/Posters

Four cycles of chemotherapy and regional radiation therapy for early stage Hodgkin's disease. High complete remission percentage, disease free survival and low toxic...
Straus, D.J., Myers, J., Lee, B.J., Koziner, B., Nisce, L.Z., Redman, J., Kirsch, J., Bajorunas, D., Clarkson, B.D., Proceedings of the American Society of Clinical Oncology, 1/1/1989
Randomized comparison of two different chemotherapy programs (MOPP vs TBV) with segmental radiotherapy in clinical stages IA, IIA and IIIA Hodgkin's disease.
Koziner, B., Myers, J., Kirsch, J., Redman, J., Bajorunas, D., Nisce, L., Straus, D., Lee, B.J., Fuks, Z., Clarkson, B., Proceedings of the American Society of Clinical Oncology, 1/1/1987
Phase II study of oral BW 301-U in non-small cell lung cancer.
Kirsch, J., Gralla, R., Kris, M., Burke, M., Kelsen, D., Heelan, R., Proceeding of the American Association for Cancer Research, 1/1/1986
Serum lactate dehydrogenase (LDH) isozymes in patients with stage III non-small cell lung cancer.
Kirsch, J., Gralla, R., Kris, M., Burke, M., Golbey, R., Proceedings of the American Society of Clinical Oncology, 1/1/1986
Ovarian function in women treated with combined modality therapy of oral contraceptives in preserving ovarian function.
Redman, J., Kirsch, J., Koziner, B., Bajorunas, D., Proceedings of the American Society of Clinical Oncology, 1/1/1986
Join now to see all